View Report Details
Global Breast Cancer Market Report ----------------------------------------2014
View Report Details Executive Summary
Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women. Breast cancer knows no boundaries be it age, gender, socioeconomic status or geographic location. The most common risk factors for breast cancer are being female and growing older. In the past few years, the cases of breast cancer have increased tremendously in regions like the US and the Europe. The breast cancer market is driven by various factors like aging population in women, obesity and diabetes, hormonal factors, race and ethnicity and family history. A major trend which will probably remain eternally in the breast cancer treatment industry is the fact that novel and innovative technologies and pharmaceutical molecules are always under development. Challenges associated with breast cancer are like costs of treatment, regulatory measures and adverse effects of the treatment on patients. The market for breast cancer drugs represents an area of potential opportunity in both developed and developing countries. Due to effectiveness and advancements in technology, a large number of companies are focusing to develop innovative breast cancer drugs. Further, the companies are forming alliances and agreements to develop effective treatment methods for breast cancer. The present report provides a comprehensive analysis of the global breast cancer diagnosis and treatment market with focus on regions like the US, India, China and Brazil. Furthermore, market dynamics such as the industry trends and development, the underlying growth drivers and major issues faced by the industry are elicited. On the contention front, the market is personified by the intense competition in terms of research and development of novel therapeutic molecules. The leading players operating in the industry include Hologic, Johnson and Johnson, Siemens AG, Roche and Novartis which are also profiled in this report.
Breast cancer is the most commonly diagnosed cancer in women. Cancer cases have been increasing at a rate of 3.1% per year …………………. Global Oncology Spending (2010-2014E)
The global oncology sales were US$.... billion in 2012 which are poised to reach US$ billion in 2014.
US$ Billion
The global market for predictive breast cancer diagnostic and drug technologies can be divided into four categories . The US breast imaging systems market generated revenues worth US$... billion in 2012 which is reckoned to reach US$.... billion in 2014. The median age for a breast cancer diagnosis in White women in the US. is 61, for African American women it is 57.
2010
2011
2012
2013E
2014E
The US Breast Imaging Systems Market (2010-2014E)
US$ Million
Global Breast Cancer Market by Segments (2013E)
Breast Cancer Drugs
Quantitative immunoflourescence
Genomic analysis
IHC and FISH
2010
2011
2012
2013E
2014E
Global Breast Cancer Market Report Brazil’s Breast Cancer Imaging Market (2010-2014E)
The breast cancer imaging market in China is expected to grow from a value of US$...million in 2012 to US$... million in 2014, at a CAGR of ..%.
US$ Million
According to the World Health Organization, low survival rates in less developed countries are due to a lack of early detection programs in concert with a lack of adequate diagnosis and treatment facilities. The Indian breast cancer imaging market is anticipated to grow from US$... million in 2012 to US$...million by 2014 at a CAGR of …%.
2010
2011
2012
2013E
2014E
India’s Breast Screening Market (2010-2014E)
US$ Million
US$ Million
China’s Breast Screening Market (2010-2014E)
2010
2011
2012
2013E
2014E
2010
2011
2012
2013E
2014E
Therapeutics market is one of the fastest growing markets globally. The rising ageing population along with increasing prevalence of chronic diseases such as, cancer, diabetes, cardiovascular diseases, and rising penetration of medical insurance are some of the prominent factors that are driving the superfluous growth of the industry.
Breast Cancer Therapeutics Market by Region
US
Japan
Italy
Canada
Others
•
The US had the largest breast cancer therapeutics market in 2013, valued at US$... billion, equivalent to a global share of ….%.
•
Canada had the lowest market share but is expected to witness rapid growth during 2014-2020 with a CAGR of ….%.
•
More than one billion adults are overweight worldwide and at least 25% of the overweight population is obese, which is a one of the risk factors for breast cancer.
•
According to the American Cancer Society, about 1 out of 8 invasive breast cancers develop in women younger than 45. About 2 out of 3 invasive breast cancers are found in women 55 or older.
View Report Contact Us:Details These are abridged and sanitized sample pages from the comprehensive report on the “ Global Breast Cancer Market Report ”. To know more about this report or for any customized research requirement, please contact the following:
Koncept Analytics
Vikas Gupta BD Manager
CS-36, Second Floor, Ansal Plaza Vaishali, Ghaziabad, U.P. – 201010 T. +91-120-4130959 C: +91-9811715635 vikas@konceptanalytics.com
www.konceptanalytics.com